87 related articles for article (PubMed ID: 1340221)
21. Informed consent and Huntington disease: a model for communication.
Sharpe NF
Am J Med Genet; 1994 Apr; 50(3):239-46. PubMed ID: 8042667
[TBL] [Abstract][Full Text] [Related]
22. Change in attitudes toward presymptomatic testing in Huntington disease.
Mastromauro C; Myers RH; Berkman B
Am J Med Genet; 1986 Jun; 24(2):369-71. PubMed ID: 3013007
[No Abstract] [Full Text] [Related]
23. Reluctance to undergo predictive testing: the case of Huntington disease.
Quaid KA; Morris M
Am J Med Genet; 1993 Jan; 45(1):41-5. PubMed ID: 8418657
[TBL] [Abstract][Full Text] [Related]
24. Self-selection in predictive testing for Huntington's disease.
Codori AM; Hanson R; Brandt J
Am J Med Genet; 1994 Sep; 54(3):167-73. PubMed ID: 7810574
[TBL] [Abstract][Full Text] [Related]
25. Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington Disease.
Babul R; Adam S; Kremer B; Dufrasne S; Wiggins S; Huggins M; Theilmann J; Bloch M; Hayden MR
JAMA; 1993 Nov; 270(19):2321-5. PubMed ID: 8230594
[TBL] [Abstract][Full Text] [Related]
26. Genetic linkage analysis and presymptomatic testing in Huntington's disease. First report in Italy.
Di Maio L; Boiano S; Squitieri F; Napolitano G; Cocozza S; Campanella G; Battistuzzi G
Acta Neurol (Napoli); 1992; 14(4-6):524-9. PubMed ID: 1363459
[TBL] [Abstract][Full Text] [Related]
27. The complexity of reproductive decision-making in asymptomatic carriers of the Huntington mutation.
Decruyenaere M; Evers-Kiebooms G; Boogaerts A; Philippe K; Demyttenaere K; Dom R; Vandenberghe W; Fryns JP
Eur J Hum Genet; 2007 Apr; 15(4):453-62. PubMed ID: 17245406
[TBL] [Abstract][Full Text] [Related]
28. Psychological distress in the 5-year period after predictive testing for Huntington's disease.
Decruyenaere M; Evers-Kiebooms G; Cloostermans T; Boogaerts A; Demyttenaere K; Dom R; Fryns JP
Eur J Hum Genet; 2003 Jan; 11(1):30-8. PubMed ID: 12529703
[TBL] [Abstract][Full Text] [Related]
29. [A prognostic test of Huntington disease--detailed interviews with persons at risk].
Mattsson B; Almqvist EW
Lakartidningen; 1990 Oct; 87(40):3204-6. PubMed ID: 2146453
[No Abstract] [Full Text] [Related]
30. [Presymptomatic DNA diagnosis in Huntington chorea with linked DNA markers].
Thies U; Schröder K; Bockel B; Zoll B; Lange H
Nervenarzt; 1991 Oct; 62(10):615-20. PubMed ID: 1684226
[No Abstract] [Full Text] [Related]
31. Psychosocial effects of predictive testing for Huntington's disease.
Hayden MR; Bombard Y
Adv Neurol; 2005; 96():226-39. PubMed ID: 16383222
[No Abstract] [Full Text] [Related]
32. Presymptomatic DNA-testing for Huntington disease: pretest attitudes and expectations of applicants and their partners in the Dutch program.
Tibben A; Frets PG; van de Kamp JJ; Niermeijer MF; Vegter-van der Vlis M; Roos RA; van Ommen GJ; Duivenvoorden HJ; Verhage F
Am J Med Genet; 1993 May; 48(1):10-6. PubMed ID: 8357031
[TBL] [Abstract][Full Text] [Related]
33. Long-term impact of Huntington disease linkage testing.
Taylor CA; Myers RH
Am J Med Genet; 1997 Jun; 70(4):365-70. PubMed ID: 9182776
[TBL] [Abstract][Full Text] [Related]
34. Predictive testing for Huntington disease: are we ready for widespread community implementation?
Hayden MR
Am J Med Genet; 1991 Sep; 40(4):515-7. PubMed ID: 1836106
[No Abstract] [Full Text] [Related]
35. Testing for the Huntington gene: a right to know, a right not to know, or a duty to know.
Shaw MW
Am J Med Genet; 1987 Feb; 26(2):243-6. PubMed ID: 2949608
[No Abstract] [Full Text] [Related]
36. Presymptomatic testing for Huntington's disease by linkage and by direct mutation analysis: comparison of uptake of testing and characteristics of test applicants.
Holloway SM; Porteous ME; Fitzpatrick DR; Crosbie AE; Cetnarskyj R; Warner J; Barron L
Genet Couns; 1998; 9(2):103-11. PubMed ID: 9664206
[TBL] [Abstract][Full Text] [Related]
37. Adverse effects of predictive testing for Huntington disease underestimated: long-term effects 7-10 years after the test.
Timman R; Roos R; Maat-Kievit A; Tibben A
Health Psychol; 2004 Mar; 23(2):189-97. PubMed ID: 15008664
[TBL] [Abstract][Full Text] [Related]
38. [Psychosocial aspects in presymptomatic testing for genetic diseases. Experiences after 2 years of counseling in Huntington disease].
Blomhoff S; Malt U; Weisaeth L
Tidsskr Nor Laegeforen; 1995 Jan; 115(1):27-9. PubMed ID: 7846655
[TBL] [Abstract][Full Text] [Related]
39. Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk.
Huggins M; Bloch M; Wiggins S; Adam S; Suchowersky O; Trew M; Klimek M; Greenberg CR; Eleff M; Thompson LP
Am J Med Genet; 1992 Feb; 42(4):508-15. PubMed ID: 1535178
[TBL] [Abstract][Full Text] [Related]
40. Attitudes of those at risk for Huntington's disease toward presymptomatic provocative testing.
McCormack MK; Lazzarini A
N Engl J Med; 1982 Nov; 307(22):1406. PubMed ID: 6215584
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
